Abstract:Background: An increasing number of adult individuals are at risk of vitamin B12 deficiency, either from reduced nutritional intake or impaired gastrointestinal B12 absorption. Objective: This study aims to review the current best practices for the diagnosis and treatment of individuals with vitamin B12 deficiency. Methods: A narrative literature review of the diagnosis and treatment of vitamin B12 deficiency. Results: Prevention and early treatment of B12 deficiency is essential to avoid irreversible neurological consequences. Diagnosis is often difficult due to diverse symptoms, marked differences in diagnostic assays' performance and the unreliability of second-line biomarkers, including holo-transcobalamin, methylmalonic acid and total homocysteine. Reduced dietary intake of B12 requires oral supplementation. In B12 malabsorption, oral supplementation is likely insufficient, and parenteral (i.e. intramuscular) supplementation is preferred. There is no consensus on the optimal long-term management of B12 deficiency with intramuscular therapy. According to the British National Formulary guidelines, many individuals with B12 deficiency due to malabsorption can be managed with 1000 µg intramuscular hydroxocobalamin once every two months after the initial loading. Long-term B12 supplementation is effective and safe, but responses to treatment may vary considerably. Clinical and patient experience strongly suggests that up to 50% of individuals require individualized injection regimens with more frequent administration, ranging from daily or twice weekly to every 2-4 weeks, to remain symptom-free and maintain a normal quality of life. 'Titration' of injection frequency based on measuring biomarkers such as serum B12 or MMA should not be practiced. There is currently no evidence to support that oral/sublingual supplementation can safely and effectively replace injections. Conclusions: This study highlights the interindividual differences in symptomatology and treatment of people with B12 deficiency. Treatment follows an individualized approach, based on the cause of the deficiency, and tailored to help someone to become and remain symptom-free.

The Role of Cobalamin in Multiple Sclerosis: An Update

The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update

Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats

Therapeutic Role of Vitamin D in Multiple Sclerosis: An Essentially Contested Concept

Multiple sclerosis and vitamin D: an update

Impact of Vitamin D Supplementation on Multiple Sclerosis

The role of diet in multiple sclerosis: A review

The Role of Gut-derived Short-Chain Fatty Acids in Multiple Sclerosis

A Brief Review of the Effects of Vitamin D on Multiple Sclerosis

The Effect of Vitamin B12 and Folic Acid Supplementation on Serum Homocysteine, Anemia Status and Quality of Life of Patients with Multiple Sclerosis

Vitamin D in Multiple Sclerosis: A Comprehensive Umbrella Review

Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications

Exploring the Therapeutic Potential: Bioactive Molecules and Dietary Interventions in Multiple Sclerosis Management

A Brief Overview of the Diagnosis and Treatment of Cobalamin (B12) Deficiency

Patients’ experiences with methylcobalamin injections in amyotrophic lateral sclerosis

Clinical implications of a possible role of vitamin D in multiple sclerosis

Endoplasmic reticulum's role in multiple sclerosis, exploring potential biomarkers, and pioneering therapeutic strategies: a comprehensive review of literature

Management of Alzheimer's disease and related neurotoxic pathologies: Role of thiamine, pyridoxine and cobalamin

The potential roles of amino acids and their major derivatives in the management of multiple sclerosis

A review of possible therapies for multiple sclerosis